The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antidotes-Global Market Insights and Sales Trends 2024
Synopsis
Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.
The global Antidotes market size is expected to reach US$ 10600 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antidotes in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Antidotes market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.
Global Antidote key players include Roche, Pfizer, Bayer, etc. Global top three manufacturers hold a share about 15%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share about 50 percent.
In terms of product, Chemical Antidotes is the largest segment, with a share about 45%. And in terms of application, the largest application is Pesticide Poisoning, followed by Heavy Metal Poisoning.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antidotes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antidotes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antidotes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antidotes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antidotes covered in this report include Baxter, Fresenius Kabi, Sandoz, Roche, Mylan, Pfizer, Teva, Glaxosmithkline and Merck, etc.
The global Antidotes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
Fresenius Kabi
Sandoz
Roche
Mylan
Pfizer
Teva
Glaxosmithkline
Merck
Global Antidotes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antidotes market, Segment by Type:
Injection
Oral
Global Antidotes market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antidotes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antidotes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.
The global Antidotes market size is expected to reach US$ 10600 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antidotes in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Antidotes market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Oral segment is estimated at % CAGR for the next seven-year period.
Global Antidote key players include Roche, Pfizer, Bayer, etc. Global top three manufacturers hold a share about 15%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share about 50 percent.
In terms of product, Chemical Antidotes is the largest segment, with a share about 45%. And in terms of application, the largest application is Pesticide Poisoning, followed by Heavy Metal Poisoning.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antidotes, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antidotes market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antidotes market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antidotes sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antidotes covered in this report include Baxter, Fresenius Kabi, Sandoz, Roche, Mylan, Pfizer, Teva, Glaxosmithkline and Merck, etc.
The global Antidotes market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Baxter
Fresenius Kabi
Sandoz
Roche
Mylan
Pfizer
Teva
Glaxosmithkline
Merck
Global Antidotes market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antidotes market, Segment by Type:
Injection
Oral
Global Antidotes market, by Application
Hospital
Clinic
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antidotes manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antidotes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antidotes Market Overview
1.1 Antidotes Product Overview
1.2 Antidotes Market Segment by Type
1.2.1 Injection
1.2.2 Oral
1.3 Global Antidotes Market Size by Type
1.3.1 Global Antidotes Market Size Overview by Type (2018-2029)
1.3.2 Global Antidotes Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antidotes Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antidotes Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antidotes Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antidotes Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antidotes Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antidotes Sales Breakdown by Type (2018-2023)
2 Global Antidotes Market Competition by Company
2.1 Global Top Players by Antidotes Sales (2018-2023)
2.2 Global Top Players by Antidotes Revenue (2018-2023)
2.3 Global Top Players by Antidotes Price (2018-2023)
2.4 Global Top Manufacturers Antidotes Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antidotes Market Competitive Situation and Trends
2.5.1 Antidotes Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antidotes Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antidotes as of 2022)
2.7 Date of Key Manufacturers Enter into Antidotes Market
2.8 Key Manufacturers Antidotes Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antidotes Status and Outlook by Region
3.1 Global Antidotes Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antidotes Historic Market Size by Region
3.2.1 Global Antidotes Sales in Volume by Region (2018-2023)
3.2.2 Global Antidotes Sales in Value by Region (2018-2023)
3.2.3 Global Antidotes Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antidotes Forecasted Market Size by Region
3.3.1 Global Antidotes Sales in Volume by Region (2024-2029)
3.3.2 Global Antidotes Sales in Value by Region (2024-2029)
3.3.3 Global Antidotes Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antidotes by Application
4.1 Antidotes Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Antidotes Market Size by Application
4.2.1 Global Antidotes Market Size Overview by Application (2018-2029)
4.2.2 Global Antidotes Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antidotes Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antidotes Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antidotes Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antidotes Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antidotes Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antidotes Sales Breakdown by Application (2018-2023)
5 North America Antidotes by Country
5.1 North America Antidotes Historic Market Size by Country
5.1.1 North America Antidotes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antidotes Sales in Volume by Country (2018-2023)
5.1.3 North America Antidotes Sales in Value by Country (2018-2023)
5.2 North America Antidotes Forecasted Market Size by Country
5.2.1 North America Antidotes Sales in Volume by Country (2024-2029)
5.2.2 North America Antidotes Sales in Value by Country (2024-2029)
6 Europe Antidotes by Country
6.1 Europe Antidotes Historic Market Size by Country
6.1.1 Europe Antidotes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antidotes Sales in Volume by Country (2018-2023)
6.1.3 Europe Antidotes Sales in Value by Country (2018-2023)
6.2 Europe Antidotes Forecasted Market Size by Country
6.2.1 Europe Antidotes Sales in Volume by Country (2024-2029)
6.2.2 Europe Antidotes Sales in Value by Country (2024-2029)
7 Asia-Pacific Antidotes by Region
7.1 Asia-Pacific Antidotes Historic Market Size by Region
7.1.1 Asia-Pacific Antidotes Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antidotes Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antidotes Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antidotes Forecasted Market Size by Region
7.2.1 Asia-Pacific Antidotes Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antidotes Sales in Value by Region (2024-2029)
8 Latin America Antidotes by Country
8.1 Latin America Antidotes Historic Market Size by Country
8.1.1 Latin America Antidotes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antidotes Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antidotes Sales in Value by Country (2018-2023)
8.2 Latin America Antidotes Forecasted Market Size by Country
8.2.1 Latin America Antidotes Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antidotes Sales in Value by Country (2024-2029)
9 Middle East and Africa Antidotes by Country
9.1 Middle East and Africa Antidotes Historic Market Size by Country
9.1.1 Middle East and Africa Antidotes Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antidotes Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antidotes Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antidotes Forecasted Market Size by Country
9.2.1 Middle East and Africa Antidotes Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antidotes Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Baxter
10.1.1 Baxter Company Information
10.1.2 Baxter Introduction and Business Overview
10.1.3 Baxter Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Baxter Antidotes Products Offered
10.1.5 Baxter Recent Development
10.2 Fresenius Kabi
10.2.1 Fresenius Kabi Company Information
10.2.2 Fresenius Kabi Introduction and Business Overview
10.2.3 Fresenius Kabi Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Fresenius Kabi Antidotes Products Offered
10.2.5 Fresenius Kabi Recent Development
10.3 Sandoz
10.3.1 Sandoz Company Information
10.3.2 Sandoz Introduction and Business Overview
10.3.3 Sandoz Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sandoz Antidotes Products Offered
10.3.5 Sandoz Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roche Antidotes Products Offered
10.4.5 Roche Recent Development
10.5 Mylan
10.5.1 Mylan Company Information
10.5.2 Mylan Introduction and Business Overview
10.5.3 Mylan Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mylan Antidotes Products Offered
10.5.5 Mylan Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Antidotes Products Offered
10.6.5 Pfizer Recent Development
10.7 Teva
10.7.1 Teva Company Information
10.7.2 Teva Introduction and Business Overview
10.7.3 Teva Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Antidotes Products Offered
10.7.5 Teva Recent Development
10.8 Glaxosmithkline
10.8.1 Glaxosmithkline Company Information
10.8.2 Glaxosmithkline Introduction and Business Overview
10.8.3 Glaxosmithkline Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Glaxosmithkline Antidotes Products Offered
10.8.5 Glaxosmithkline Recent Development
10.9 Merck
10.9.1 Merck Company Information
10.9.2 Merck Introduction and Business Overview
10.9.3 Merck Antidotes Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Merck Antidotes Products Offered
10.9.5 Merck Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antidotes Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antidotes Industrial Chain Analysis
11.4 Antidotes Market Dynamics
11.4.1 Antidotes Industry Trends
11.4.2 Antidotes Market Drivers
11.4.3 Antidotes Market Challenges
11.4.4 Antidotes Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antidotes Distributors
12.3 Antidotes Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
